Tag immunogenicity [40 articles] Export

Recent papers classified by the tag immunogenicity.

	Immunogenicity of Toxins during Staphylococcus aureus Infection. [My Copy] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 0, No. 0. (30 November 2009), pp. 000-000. by Nelianne J. Verkaik, Olivier Dauwalder, Kenza Antri, et al.Ilhem Boubekri, Corné P. de Vogel, Cédric Badiou, Michèle Bes, François Vandenesch, Mohamed Tazir, Herbert Hooijkaas, Henri A. Verbrugh, Alex van Belkum, Jerome Etienne, Gerard Lina, Nadjia Ramdani-Bouguessa, Willem J. van Wamel posted to staphylococcus_aureus immunogenicity by Amazoness on 2009-12-11 03:44:04 as
	Epitopia: a web-server for predicting B-cell epitopes [My Copy] BMC Bioinformatics, Vol. 10, No. 1. (14 September 2009), 287. by Nimrod Rubinstein, Itay Mayrose, Eric Martz, Tal Pupko posted to web_server structure-prediction structure protein_structure protein_sequence prediction_tools immunoinformatics immunogenicity epitope_prediction epitope computational_tool cell_epitopes b_cell by niallhaslam on 2009-09-16 12:08:27 as
	NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast Tumors [My Copy] Cancer Res, Vol. 64, No. 6. (15 March 2004), pp. 2199-2204. by Yurika Sugita, Hisashi Wada, Shoichiro Fujita, et al.Tetsuya Nakata, Shuichiro Sato, Yuji Noguchi, Achim A. Jungbluth, Masae Yamaguchi, Yao-Tseng Chen, Elisabeth Stockert, Sacha Gnjatic, Barbara Williamson, Matthew J. Scanlan, Toshiro Ono, Isao Sakita, Masayoshi Yasui, Yasuo Miyoshi, Yasuhiro Tamaki, Nariaki Matsuura, Shinzaburo Noguchi, Lloyd J. Old, Eiichi Nakayama, Morito Monden posted to cancer grade immunogenicity breast thelist superlist by Zephyrus on 2009-05-27 19:31:53 as along with 1 person bwang
	Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy [My Copy] Journal of Translational Medicine, Vol. 3, No. 1. (2005) by Christine Ichim posted to control-models immune-systems immunogenicity immunomodulators immunostimulating immunostimulation immunostimulators immunotherapy modulating regulating regulative-structures regulators by Scis0000002 on 2009-04-28 21:37:04 as along with 1 person Zephyrus
	Immunological Risk of Injectable Drug Delivery Systems [My Copy] Pharmaceutical Research by Wim Jiskoot, Rianne van Schie, Myrra Carstens, Huub Schellekens posted to antibodies biocompatibility drug_delivery immunogenicity immunology microparticles nanoparticles review by monkare on 2009-03-13 14:47:59 as
	Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. [My Copy] Journal of immunological methods, Vol. 278, No. 1-2. (July 2003), pp. 1-17. by M. Wadhwa, C. Bird, P. Dilger, R. Gaines-Das, R. Thorpe posted to immunogenicity by roslyn on 2008-11-19 00:56:44 as
	A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs [My Copy] Nature Biotechnology, Vol. 25, No. 5. (04 May 2007), pp. 555-561. by Gopi Shankar, Charles Pendley, Kathryn E. Stein posted to immunogenicity by roslyn on 2008-11-19 00:49:16 as
	Scientific and regulatory considerations on the immunogenicity of biologics. [My Copy] Trends in biotechnology, Vol. 24, No. 6. (June 2006), pp. 274-280. by G. Shankar, E. Shores, C. Wagner, A. Mire-Sluis posted to immunogenicity by roslyn on 2008-11-19 00:48:33 as
	Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics. [My Copy] Journal of immunological methods, Vol. 321, No. 1-2. (10 April 2007), pp. 1-18. by S. Gupta, S. R. Indelicato, V. Jethwa, et al.T. Kawabata, M. Kelley, A. R. Mire-Sluis, S. M. Richards, B. Rup, E. Shores, S. J. Swanson, E. Wakshull posted to immunogenicity neutralising validation by roslyn on 2008-11-19 00:26:30 as
	Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. [My Copy] Journal of pharmaceutical and biomedical analysis, Vol. 48, No. 5. (15 December 2008), pp. 1267-1281. by Gopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.Yu Chen C. Barrett, Ronald Bowsher, Deborah Finco-Kent, Michele Fiscella, Boris Gorovits, Susan Kirschner, Michael Moxness, Thomas Parish, Valerie Quarmby, Holly Smith, Wendell Smith, Linda A. Zuckerman, Eugen Koren posted to immunogenicity validation by roslyn on 2008-11-19 00:25:42 as
	Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. [My Copy] Journal of immunological methods, Vol. 333, No. 1-2. (20 April 2008), pp. 1-9. by E. Koren, H. W. Smith, E. Shores, et al.G. Shankar, D. Finco-Kent, B. Rup, Y. C. Barrett, V. Devanarayan, B. Gorovits, S. Gupta, T. Parish, V. Quarmby, M. Moxness, S. J. Swanson, G. Taniguchi, L. A. Zuckerman, C. C. Stebbins, A. Mire-Sluis posted to immunogenicity by roslyn on 2008-11-19 00:20:53 as along with 1 person sahrazanetti
	Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies. [My Copy] Clinical chemistry, Vol. 51, No. 10. (October 2005), pp. 1983-1985. by M. Moxness, S. Tatarewicz, D. Weeraratne, et al.N. Murakami, D. Wullner, D. Mytych, V. Jawa, E. Koren, S. J. Swanson posted to ecl immunogenicity by roslyn on 2008-11-19 00:14:54 as
	Challenges with current technology for the detection, measurement and characterization of antibodies against biological therapeutics. [My Copy] Developments in biologicals, Vol. 109 (2002), pp. 59-69. by A. R. Mire-Sluis posted to immunogenicity by roslyn on 2008-11-19 00:12:56 as
	From characterization of antibodies to prediction of immunogenicity. [My Copy] Developments in biologicals, Vol. 109 (2002), pp. 87-95. by E. Koren posted to immunogenicity by roslyn on 2008-11-19 00:07:07 as
	Immunogenicity of engineered antibodies. [My Copy] Methods (San Diego, Calif.), Vol. 36, No. 1. (May 2005), pp. 3-10. by W. Y. Hwang, J. Foote posted to immunogenicity by roslyn on 2008-11-19 00:01:05 as
	Detection of anti-EPO antibodies in human sera by a bridging ELISA is much more sensitive when coating biotinylated rhEPO to streptavidin rather than using direct coating of rhEPO. [My Copy] Journal of immunological methods, Vol. 313, No. 1-2. (30 June 2006), pp. 176-182. by J. Gross, R. Moller, W. Henke, W. Hoesel posted to immunogenicity by roslyn on 2008-11-18 23:59:28 as
	Immunogenicity of therapeutic proteins: clinical implications and future prospects. [My Copy] Clinical therapeutics, Vol. 24, No. 11. (November 2002) by H. Schellekens posted to immunogenicity by roslyn on 2008-11-18 23:31:51 as along with 1 person sahrazanetti
	Antibodies against erythropoietin and other protein-based therapeutics: an overview. [My Copy] Annals of the New York Academy of Sciences, Vol. 1050 (June 2005), pp. 257-265. by A. Kromminga, H. Schellekens posted to immunogenicity review by roslyn on 2008-11-18 23:01:55 as
	Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. [My Copy] Rheumatology (Oxford, England), Vol. 46, No. 12. (December 2007), pp. 1828-1834. by M. Svenson, P. Geborek, T. Saxne, K. Bendtzen posted to immunogenicity pharmacokinetics by roslyn on 2008-11-18 22:42:41 as along with 1 person sahrazanetti
	Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. [My Copy] Arthritis and rheumatism, Vol. 54, No. 12. (December 2006), pp. 3782-3789. by K. Bendtzen, P. Geborek, M. Svenson, L. Larsson, M. C. Kapetanovic, T. Saxne posted to immunogenicity by roslyn on 2008-11-18 22:41:49 as
	How to predict and prevent the immunogenicity of therapeutic proteins. [My Copy] Biotechnology annual review, Vol. 14 (2008), pp. 191-202. by H. Schellekens posted to immunogenicity by roslyn on 2008-11-06 23:32:16 as along with 1 person sahrazanetti
	A novel method for quantitative measurement of a biomarker in the presence of a therapeutic monoclonal antibody directed against the biomarker. [My Copy] Journal of pharmaceutical and biomedical analysis, Vol. 48, No. 3. (4 November 2008), pp. 897-901. by R. A. Davis, A. M. Butterfield, R. J. Konrad, J. S. Bourdage posted to acid-dissociation immunogenicity by roslyn on 2008-10-23 05:50:06 as
	Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 178, No. 11. (1 June 2007), pp. 7467-7472. by J. A. Lofgren, S. Dhandapani, J. J. Pennucci, et al.C. M. Abbott, D. T. Mytych, A. Kaliyaperumal, S. J. Swanson, M. C. Mullenix posted to antibody immunogenicity by roslyn on 2008-10-22 03:53:39 as
	Animal models as indicators of immunogenicity of therapeutic proteins in humans. [My Copy] Developments in biologicals, Vol. 112 (2003), pp. 135-139. by J. L. Bussiere posted to immunogenicity by roslyn on 2008-10-19 05:54:57 as along with 1 person sahrazanetti
	Immunogenicity of biopharmaceuticals in laboratory animals. [My Copy] Toxicology, Vol. 158, No. 1-2. (2 February 2001), pp. 71-74. by D. Wierda, H. W. Smith, C. M. Zwickl posted to immunogenicity by roslyn on 2008-10-17 04:31:09 as along with 1 person sahrazanetti
	Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. [My Copy] Investigational new drugs, Vol. 26, No. 1. (February 2008), pp. 35-43. by C. Delbaldo, E. Raymond, K. Vera, et al.L. Hammershaimb, K. Kaucic, S. Lozahic, M. Marty, S. Faivre posted to antibody biologics immunogenicity by sahrazanetti on 2008-10-04 06:39:57 as
	Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, No. 20. (15 October 2007), pp. 6187-6194. by R. Plummer, G. Attard, S. Pacey, et al.L. Li, A. Razak, R. Perrett, M. Barrett, I. Judson, S. Kaye, N. L. Fox, W. Halpern, A. Corey, H. Calvert, J. de Bono posted to antibody biologics immunogenicity by sahrazanetti on 2008-10-04 06:38:34 as
	Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis. [My Copy] The Journal of rheumatology, Vol. 34, No. 12. (December 2007), pp. 2365-2373. by H. G. Haggerty, M. A. Abbott, T. P. Reilly, et al.D. A. DeVona, C. R. Gleason, L. Tay, R. Dodge, R. Aranda posted to biologics immunogenicity by sahrazanetti on 2008-10-04 06:35:59 as
	Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. [My Copy] Critical reviews in oncology/hematology, Vol. 62, No. 1. (April 2007), pp. 34-42. by S. Loisel, M. Ohresser, M. Pallardy, et al.D. Daydé, C. Berthou, G. Cartron, H. Watier posted to animals biologics immunogenicity by sahrazanetti on 2008-10-03 19:11:33 as
	Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans. [My Copy] Current opinion in molecular therapeutics, Vol. 6, No. 1. (February 2004), pp. 10-16. by P. J. Bugelski, G. Treacy posted to animals humans immunogenicity preclinical by sahrazanetti on 2008-10-03 19:08:15 as
	Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction. [My Copy] Current pharmaceutical biotechnology, Vol. 3, No. 4. (December 2002), pp. 349-360. by E. Koren, L. A. Zuckerman, A. R. Mire-Sluis posted to biologics immunogenicity by sahrazanetti on 2008-10-03 19:05:56 as
	Immunogenicity of protein therapeutics. [My Copy] Trends in immunology, Vol. 28, No. 11. (November 2007), pp. 482-490. by A. S. De Groot, D. W. Scott posted to b biologics immunogenicity by sahrazanetti on 2008-10-03 19:04:48 as
	Identification and removal of immunogenicity in therapeutic proteins. [My Copy] Current opinion in drug discovery & development, Vol. 10, No. 2. (March 2007), pp. 219-227. by M. P. Baker, T. D. Jones posted to biologics immunogenicity by sahrazanetti on 2008-10-03 19:04:07 as
	Prediction of immunogenicity for therapeutic proteins: state of the art. [My Copy] Current opinion in drug discovery & development, Vol. 10, No. 3. (May 2007), pp. 332-340. by A. S. De Groot, L. Moise posted to biologics immunogenicity by sahrazanetti on 2008-10-03 19:03:17 as
	Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. [My Copy] Current opinion in pharmacology (19 September 2008) by Anne S S. De Groot, Julie McMurry, Lenny Moise posted to immunogenicity by sahrazanetti on 2008-10-03 19:02:30 as
	Learning MHC I--peptide binding [My Copy] Bioinformatics, Vol. 22, No. 14. (15 July 2006), pp. e227-235. by Nebojsa Jojic, Manuel Reyes-Gomez, David Heckerman, Carl Kadie, Ora Schueler-Furman posted to immunogenicity by bobychan on 2008-05-22 22:16:09 as along with 1 person operon
	Coiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for Virulence [My Copy] Science, Vol. 319, No. 5868. (7 March 2008), pp. 1405-1408. by Case McNamara, Annelies S. Zinkernagel, Pauline Macheboeuf, Madeleine W. Cunningham, Victor Nizet, Partho Ghosh posted to fibrinogen immunogenicity immunogens inflammation pathogen protein structure vaccine by davidlott on 2008-03-11 19:02:28 as along with 3 people loison oteri phoenixzxl
	The dendritic cell system and its role in immunogenicity. [My Copy] Annu Rev Immunol, Vol. 9 (1991), pp. 271-296. by R. M. Steinman posted to dc immunogenicity by philill on 2006-11-21 16:08:59 as
	Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia [My Copy] British Journal of Haematology, Vol. 129, No. 4. (May 2005), pp. 499-510. by Katja Mauerer, David Zahrieh, Gullu Gorgun, et al.Aihong Li, Jianbiao Zhou, Sascha Ansen, Laura Z. Rassenti, John G. Gribben posted to b-cll cll immunogenicity immunoglobulin by philill on 2006-11-17 20:58:00 as
	Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicity. [My Copy] Gene Ther, Vol. 11, No. 13. (July 2004), pp. 1099-1104. by M. J. Gough, A. A. Melcher, M. R. Crittenden, L. Sanchez-Perez, R. Voellmy, R. G. Vile posted to gene hsp70 immunogenicity immunotherapy transfer tumor by smihalcik on 2006-06-07 19:22:37 as

Note: You may cite this page as: http://www.citeulike.org/tag/immunogenicity

biologics	14
animals	4
antibody	4
validation	4
review	3
acid-dissociation	2
antibodies	2
ecl	2
immunotherapy	2
neutralising	2
pharmacokinetics	2
structure	2
antibody_response	1
antigenicity	1
b	1
b-cll	1
b_cell	1
biacore	1
biocompatibility	1
breast	1
cancer	1
cell_epitopes	1
cll	1
computational_tool	1
control-models	1
dc	1
drug_delivery	1
elisa	1
epitope	1
epitope_prediction	1
fibrinogen	1
gene	1
grade	1
hsp70	1
humans	1
immune-systems	1
immunogens	1
immunoglobulin	1
immunoinformatics	1
immunology	1
immunomodulators	1
immunostimulating	1
immunostimulation	1
immunostimulators	1
inflammation	1
microparticles	1
modulating	1
nanoparticles	1
p28	1
pathogen	1
preclinical	1
prediction_tools	1
protein	1
protein_sequence	1
protein_structure	1
reactivity	1
recent_developments	1
regulating	1
regulative-structures	1
regulators	1
staphylococcus_aureus	1
structure-prediction	1
superlist	1
thelist	1
transfer	1
tumor	1
vaccine	1
web_server	1

Tag immunogenicity [40 articles] Export

Related Tags